Request FREE sample PDF
Pharmacy benefit management market
Automatic External Defibrillator Market Report Overview
The global automatic external defibrillator market size was USD 3.061 billion in 2023, & the market is expected to reach USD 12.58 billion in 2032, exhibiting a CAGR of 17.01% during the forecast period. Philips, Zoll, Physio-Control, Laerdal Medical, Cardiac Science, Nihon Kohden, Schiller, HeartSine Technologies, A.M.I. Italia, Defibtech, Philips, Mediana, Instramed, METsis Medikal, Mindray are the top companies operating in the automatic external defibrillator market.
The global COVID-19 pandemic has been unprecedented and staggering, with automatic external defibrillator experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden decline in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
An apparatus that automates the delivery of an electric shock to the heart is an external defibrillator (AED). Someone who is having cardiac arrest may benefit from this shock by regaining a regular heartbeat. AEDs are crucial because they can be used to treat sudden cardiac arrest, which, if not treated right away, can result in death.
Over the projected period, the fully automatic external defibrillator market is anticipated to rise due to the rising incidence of cardiac arrest cases and public safety awareness. The global fully automatic external defibrillator (HeartStart Home Defibrillation System) market size is also anticipated to be driven by the healthcare sector's rapid technical improvements as well as consumers' rising demand for technologically advanced goods. For instance, the HeartStart home monitoring system from Philips Healthcare was created to assist people monitor their health using mobile devices like smartphones or tablets. It offers real-time notifications on heart rate measures and blood pressure readings.
COVID-19 Impact: Market to Witness a Downfall Owing to Restrictions
Since supply chains have been disrupted owing to international restrictions and utilization has decreased due to worldwide government lockdowns, the outbreak of coronavirus sickness (COVID-19) did act as a massive restriction on almost every market in 2020. Extremely contagious COVID-19 is characterized by flu-like symptoms include fever, coughing, and breathing difficulties. Following its discovery in Wuhan, the virus has subsequently spread to North America, West Europe, and Asia. The Automatic External Defibrillator industry is one of many that Covid-19 has had a great impact on.
Automated external defibrillator manufacturers are creating strategies to protect their industry in the event of COVID-19 pandemic-related emergencies. While complying to all safety guidelines recommended by the local government officials, they are concentrated on bolstering their supply networks and carrying on with routine manufacturing activities.
Latest Trends
"Product to Help People in Cases of Emergencies"
When someone has had a cardiac arrest at home, a completely automatic external defibrillator is used in an emergency. This could result in death within minutes after suffering from sudden cardiac arrest if it is not addressed right away. A fully automatic external defibrillator, which may be purchased by people who have successfully completed the necessary training on how to use it securely and correctly while providing the necessary treatment, may be used in such situations by family members or friends. This feature of the equipment has provided relief in households and it is anticipated to boost automatic external defibrillator market growth.
Automatic External Defibrillator Market Segmentation
-
By Type Analysis
According to type, the market can be segmented into semi-automatic and fully-automatic.
In terms of product, semi-automatic is the largest segment.
-
By Application Analysis
Based on application, the market can be divided into hospitals, public access, emergency medical services, homes, work spaces and private cardiac clinics.
In terms of application, hospitals is the largest segment.
Driving Factors
"Rise in Prevalence of Cardiac Arrest Fuels Demand for Automated External Defibrillators"
The popularity of automated external defibrillators is growing as a result of its capacity to help restore abnormal heart rhythms by shocking the heart with electricity. Ventricular fibrillation (VF) and pulseless ventricular tachycardia are two non-standard cardiac rhythms that these devices are designed to detect and treat (pulseless VT). In the next years, it is predicted that increased use of this device in treating patients who have had an abrupt cardiac arrest would present potential for income generating. Furthermore, the market may see profitable opportunities as the number of persons addicted to smoking and alcohol rises.
"Offering Training Programs Intended for Device Use at Workplaces to Support Sales in Market"
Various end users, including emergency medical services, hospitals, public access, workplaces, households, and private cardiac clinics, employ automated external defibrillators. The growth in working stress levels around the world is predicted to drive demand for this technology in office settings. By teaching people how to use automated external defibrillators correctly, tragic events like cardiac arrest deaths might be avoided. As a result, many training initiatives are being run to ensure that these gadgets are used correctly in offices.
Restraining Factors
"Legal Issues Regarding the Equipment to Impede Market Expansion"
Legal concerns are raised by the growing usage of home and public defibrillators. For instance, the victim may file a lawsuit against first aid personnel who use an AED on someone who refuses to be revived. Defibrillator usage that results in a damage to a bystander, such as a shock or burn, may also give rise to a malpractice claim against a physician or a personal liability claim against a private individual.
Automatic External Defibrillator Market Regional Insights
"North America to Dominate the Market Due to Increase in Cardiac Arrests"
The global market was controlled by North America and owns largest automatic external defibrillator market share. This can be ascribed to an increase in cardiac arrests, greater product awareness, and the existence of reputable medical facilities in this area. The market for FAEBs is also anticipated to be driven by the rising adoption rate of technologically improved medical devices over the forecast period. Due to variables like expanding target populations and an area with improved healthcare infrastructure, Asia Pacific is predicted to grow profitably over the next eight years. Due to the high senior population base, which is predisposed to CVDs and thus raises their risk factor for sudden cardiac arrest, the market is expected to rise significantly over the forecast period (SCA).
Key Industry Players
"Key Players Focus on Partnerships to Gain a Competitive Advantage "
Major market participants for automated external defibrillators are placing an increasing emphasis on the creation of cutting-edge devices. As a result, they are boosting their research activity investments. Additionally, a number of producers of automated external defibrillators are working to get their most recent models approved. To keep ahead of the competition, companies are seen engaging in strategic partnerships and agreements. According to estimates, these initiatives will accelerate the demand for automated external defibrillators in the next years.
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
LIST OF TOP AUTOMATIC EXTERNAL DEFIBRILLATOR COMPANIES
- Stryker Corporation (U.S.)
- Schiller (Switzerland)
- Koninklijke Philips N.V. (Netherlands)
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd (China)
- Cardiac Science (U.S.)
- Zoll Medical Corporation (U.S.)
- Asahi Kasei Corporation (Japan)
- Nihon Kohden Corporation (Japan)
- GE Healthcare (U.S.)
- Medtronic PLC (Ireland)
Report Coverage
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 3.061 Billion in 2023 |
Market Size Value By |
US$ 12.58 Billion by 2032 |
Growth Rate |
CAGR of 17.01% from 2023 to 2032 |
Forecast Period |
2024-2032 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered | |
By Type
|
|
By Application
|
Frequently Asked Questions
-
What value is the global automatic external defibrillator market expected to touch by 2032?
The global automatic external defibrillator market is expected to touch USD 12.58 billion in 2032.
-
What CAGR is the automatic external defibrillator market expected to exhibit by 2032?
The automatic external defibrillator market is expected to exhibit a CAGR of 17.01% by 2032.
-
Which are the driving factors of the automatic external defibrillator market?
Rise in prevalence of cardiac arrest offering training programs intended for device use at workplaces are the driving factors of the automatic external defibrillator market.
-
Which are the top companies operating in the automatic external defibrillator market?
Philips, Zoll, Physio-Control, Laerdal Medical, Cardiac Science, Nihon Kohden, Schiller, HeartSine Technologies, A.M.I. Italia, Defibtech, Philips, Mediana, Instramed, METsis Medikal, Mindray are the top companies operating in the automatic external defibrillator market.